QVA@ is a novel , inhaled , once-daily dual bronchodilator containing a fixed-dose combination of the long-acting @-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium ( NVA@ ) , for the treatment of chronic obstructive pulmonary disease ( COPD ) .